𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

✍ Scribed by Rupert Bartsch; Catharina Wenzel; Simon P. Gampenrieder; Ursula Pluschnig; Gabriela Altorjai; Margaretha Rudas; Robert M. Mader; Peter Dubsky; Andrea Rottenfusser; Michael Gnant; Christoph C. Zielinski; Guenther G. Steger


Publisher
Springer
Year
2008
Tongue
English
Weight
322 KB
Volume
62
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Quantitative HER2 protein levels predict
✍ Allan Lipton; Wolfgang J. KΓΆstler; Kim Leitzel; Suhail M. Ali; Jeff Sperinde; Jo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 492 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: Only a portion of breast cancer patients currently selected for trastuzumab therapy respond. ## METHODS: Using a novel assay (HERmark) to quantify total human epidermal growth factor receptor 2 (HER2) expression, the authors examined outcomes in 102 trastuzumab‐treated